Skinvisible Announces Licensing Agreement for...( said Mr. Terry Howlett President / CEO...),Health

Date:1/30/2008

," said Mr. Terry Howlett, President / CEO of Skinvisible. "The acne market is extremely large, with retinoids like adapalene making up the largest portion with over 60% market share. We are entering the acne market with adapalene, as it is the market leader, and we are confident that dermatology companies will be interested in obtaining the rights to our Invisicare formulations incorporating adapalene, especially with our ability to seek patent protection for these products in the United States."

Skinvisible continually looks for active ingredients in dermatology products where patents are expiring such as adapalene. Adapalene was approved for the treatment of acne in 1996 by the U.S. Food and Drug Administration and will come off patent in 2010 in the United States. For the countries where no patent exists and for future U.S. distribution, Skinvisible has successfully developed both a gel and cream adapalene based product made with Invisicare and has applied for new patents. Adapalene is generic in many countries and Skinvisible is seeking to license the new formulas in those countries.

About Skinvisible Pharmaceuticals, Inc.

Skinvisible Pharmaceuticals, a wholly owned subsidiary of Skinvisible Inc., is a research-and-development company whose primary business objective is to license its proprietary formulations with Invisicare to pharmaceutical and cosmeceutical companies as well as assisting companies in revitalizing or enhancing their existing skin care products. Skinvisible receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the patent. http://www.skinvisible.com

About Invisicare(R)

Invisicare is a patented polymer delivery system developed to hold active ingredients topically on the skin for extended periods of time. Other key benefits include its ability to gradually release active ingredients which reduce
'/>"/>

SOURCE Skinvisible, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine news :

1. Skinvisible Signs Marketing Agreement for India
2. Skinvisible Appoints Dr. George Korkos to Its Advisory Board
3. Skinvisible to Present at Merriman Curhan Ford & Co.s Investor Summit 2007
4. Aflac Incorporated Announces Fourth Quarter Results
5. Hologic Announces Two-For-One Stock Split
6. Hutchinson Center Announces First Unclimbed Mountain to be Tackled by Big Expedition for Cancer Research
7. Healthcare Businesswomens Association Announces 2008 Board of Directors
8. Perdue AgriBusiness Announces Low Linolenic Soybean Contracting Opportunities with DuPont Business Pioneer Hi-Bred
9. Radius Announces Launch of RAD1901 Clinical Program for the Treatment of Hot Flashes
10. Samarion(SM) Announces Formation of Outcome Based Study Team for Industrys Only Enterprise Quality Improvement System
11. STERIS Corporation Announces Fiscal 2008 Third Quarter Results